Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-035269

EVP and Chief Medical Officer sold 10,382 shares at an average $5.47 ($56,791)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eisner Mark EVP and Chief Medical Officer 2025-07-15 Sale 10b5-1 −6,796 $5.47 $37,162 108,204 D
Eisner Mark EVP and Chief Medical Officer 2025-07-17 Sale 10b5-1 −3,586 $5.47 $19,629 104,618 D
Open-market sales · 10,382 sh · avg $5.47 · $56,791
Loading xslF345X05/wk-form4_1752792412.xml…